Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to BioNTech SE
Related studies linked through entity extraction aliases.
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
- Status
- COMPLETED
- Phase
- PHASE2
Study of a New Technique for Imaging Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3